Suppose you are a bioengineering researcher looking for a unique funding opportunity. In that case, you should attend a live webinar on The Lyda Hill Biomedical Innovation Fund. This award opportunity aims to accelerate the work of The University of…
From the moment you step through the doors of UTD’s Innovation Quarter, you can feel the energy. This newly constructed workplace is home to entrepreneurs launching startups and some top university researchers expanding their research and perspectives. This contemporary open…
On January 20th 2023, UTD’s new research center, The Center for Harsh Environment Semiconductors and Systems (CHESS) reveals their demand for materials and devices that can sustain extreme mechanical conditions, used for military procedures and assist the North Texas Semiconductor…
On October 14th 2022, the Office of Research celebrated the 2022 Research Day Poster Competition. UTD graduate students from a variety of disciplines were nominated by faculty and showcased their graduate poster for attendees to vote on. First place winner…
Beginning January 25, 2023, the National Institutes of Health (NIH) Data Management and Sharing (DMS) policy will go into effect.
At the 2022 University of Texas at Dallas State of the University address on October 20th, President Richard C. Benson presented a video highlighting the UT Dallas Spirit of Innovation. Watch the video below:
Below are the participants in the Workshop on Sustainability in Research, held on September 23, 2022.
The City of Richardson and the University of Texas at Dallas have teamed up on a powerful economic development initiative by partnering on a new Headquarters for the Richardson Innovation Quarter (the IQ HQ). A flyer has been created on…
Two staff members of the UT Dallas Research, Campus, and Environmental Safety (UTD Safety) team have received accolades for outstanding efforts as Safety Culture Champions in Community Engagement. Ms. Renée Witherspoon, UTD’s Program Manager for Occupational Hygiene and Safety, facilitated…
Dr. Heather Hayenga joins the Office of Research and Innovation to discuss the need for systemic therapy to treat hemangiopericytoma (HPC), a rare nonhereditary brain tumor caused by an environmental fusion of two genes. Fusion genes are created from the…
